Detalhe da pesquisa
1.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gynecol Oncol
; 183: 25-32, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490057
2.
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Int J Gynecol Cancer
; 30(7): 920-926, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467335
3.
Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma.
Arch Gynecol Obstet
; 301(1): 289-294, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858234
4.
Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.
Arch Gynecol Obstet
; 301(1): 273-281, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31781887
5.
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Gynecol Oncol
; 153(2): 286-291, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760408
6.
Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.
Reprod Health
; 16(1): 54, 2019 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31088503
7.
Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.
Reprod Health
; 15(1): 37, 2018 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29499716
8.
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
Ann Surg Oncol
; 24(5): 1314-1321, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27896515
9.
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).
Gynecol Oncol
; 140(3): 450-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731724
10.
Chylous ascites after lymphadenectomy for gynecological malignancies.
J Surg Oncol
; 114(5): 613-618, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378217
11.
Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Arch Gynecol Obstet
; 294(2): 343-51, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26711836
12.
Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases.
BMC Cancer
; 15: 587, 2015 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272451
13.
Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.
BMC Cancer
; 15: 751, 2015 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26487094
14.
SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
Ann Diagn Pathol
; 19(5): 283-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26123103
15.
Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed".
Reprod Health
; 16(1): 83, 2019 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31208442
16.
Comparison of reoperation rates, perioperative outcomes in women with endometrial cancer when the standard of care shifts from open surgery to laparoscopy.
Arch Gynecol Obstet
; 290(6): 1215-20, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25009071
17.
Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008.
Arch Gynecol Obstet
; 289(2): 329-35, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23912533
18.
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
Breast Cancer Res Treat
; 138(3): 899-908, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23479421
19.
Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: a study of the Arbeitsgemeinschaft Gynäkologische Onkologie.
Gynecol Oncol
; 129(3): 495-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23500091
20.
Financing of certified centers: a willingness-to-pay analysis.
Arch Gynecol Obstet
; 287(3): 495-509, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23080545